Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy
Conclusions:
Understanding demographic and clinical risk factors for ER/IP care among patients on ICIs can help highlight disparities, prospectively identify high-risk patients, and inform preventive programs aimed at reducing such care.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Immunotherapy Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Kidney Disease | Emergency Medicine | Immunotherapy | Intensive Care | Liver | Study | Toxicology | Urology & Nephrology